Inventor · disambiguated record
Wei Cheng
Also filed as: CHENG WEI · CHENG WEI-SUNG
10 granted patents·7 pending applications·22 citations·filing 2012–2025
82Inventor score
Files withE INK HOLDINGS INC7IBM4CHENG WEI2AGENCY SCIENCE TECH & RES1NANJING IASO BIOTECHNOLOGY CO LTD1
Top patents by PatentIndex Score
17 records- 0195US9399044B2Antimicrobial cationic polyaminesIBM·Filed 2014·Granted Jul 26, 2016·15 cites·40 claims
- 0291US10463746B2Macromolecular chemotherapeuticsIBM·Filed 2017·Granted Nov 5, 2019·3 cites·10 claims
- 0377US12422947B2Touch display deviceE INK HOLDINGS INC·Filed 2024·Granted Sep 23, 2025·0 cites·12 claims
- 0472US12099680B2Touch display deviceE INK HOLDINGS INC·Filed 2023·Granted Sep 24, 2024·0 cites·10 claims
- 0570US11116844B2Macromolecular chemotherapeuticsIBM·Filed 2019·Granted Sep 14, 2021·0 cites·19 claims
- 0670US9109087B2Low molecular weight branched polyamines for delivery of biologically active materialsCHENG WEI·Filed 2012·Granted Aug 18, 2015·2 cites·22 claims
- 0770US8703197B2Branched polyamines for delivery of biologically active materialsCHENG WEI·Filed 2012·Granted Apr 22, 2014·2 cites·27 claims
- 0862US11485823B2Polymer for delivery of biologically active materialsAGENCY SCIENCE TECH & RES·Filed 2018·Granted Nov 1, 2022·0 cites·20 claims
- 0961US2025298283A1Flexible display device and manufacturing method thereofE INK HOLDINGS INC·Filed 2025·Application pending·0 cites
- 1059US2025356126A1Logits-based detector without logits from black-box llmsNEC LAB AMERICA INC·Filed 2025·Application pending·0 cites
- 1154US2024288741A1Display deviceE INK HOLDINGS INC·Filed 2024·Application pending·0 cites
- 1253US2023320012A1Display device and manufacturing method of the sameE INK HOLDINGS INC·Filed 2023·Application pending·0 cites
- 1352US2024045300A1Touch display device and manufacturing method thereofE INK HOLDINGS INC·Filed 2023·Application pending·0 cites
- 1452US2024241420A1Display deviceE INK HOLDINGS INC·Filed 2023·Application pending·0 cites
- 1548US9987369B2Vitamin functionalized gel-forming block copolymers for biomedical applicationsIBM·Filed 2016·Granted Jun 5, 2018·0 cites·20 claims
- 1647US2023241212A1Fully humanized bispecific chimeric antigen receptor targeting cd19 and cd22 and use thereofNANJING IASO BIOTHERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1743US12448453B2Fully human anti-human CD22 chimeric antigen receptor and application thereofNANJING IASO BIOTECHNOLOGY CO LTD·Filed 2021·Granted Oct 21, 2025·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →